Citadel Advisors’s CAREFUSION CORPORATION CFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,300
Closed -$77K 9215
2014
Q4
$77K Sell
1,300
-5,900
-82% -$339K ﹤0.01% 6879
2014
Q3
$326K Sell
7,200
-12,400
-63% -$558K ﹤0.01% 5164
2014
Q2
$869K Buy
19,600
+13,400
+216% +$555K ﹤0.01% 3688
2014
Q1
$249K Sell
6,200
-4,700
-43% -$190K ﹤0.01% 5260
2013
Q4
$434K Sell
10,900
-25,100
-70% -$976K ﹤0.01% 4186
2013
Q3
$1.33M Sell
36,000
-72,200
-67% -$2.7M ﹤0.01% 2805
2013
Q2
$3.99M Buy
+108,200
New +$3.82M 0.01% 1777

Other funds holding CFN

Citadel Advisors's CFN Position: Q1 2015 in Review

Citadel Advisors sold out of CAREFUSION CORPORATION (CFN) in Q1 2015, closing a stake of 3,505,728 shares — an estimated $208M sold.

Citadel Advisors first reported a position in CFN in Q2 2013 and held it in 7 quarters. The position peaked at $208M in Q4 2014. 3 funds tracked by Wall St. Rank hold CFN as of Q1 2015.

  • Citadel Advisors reported no remaining CAREFUSION CORPORATION position as of Q1 2015 after selling out during the quarter.
  • Citadel Advisors sold 3,505,728 CAREFUSION CORPORATION shares in Q1 2015, an estimated $208M.
  • Citadel Advisors first reported a position in CAREFUSION CORPORATION in Q2 2013 and held it in 7 quarters.
  • Citadel Advisors's CAREFUSION CORPORATION position peaked at $208M in Q4 2014.
  • 3 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q1 2015.

Based on Citadel Advisors's 13F filing for Q1 2015, filed 15 May 2015.